Previous close | 2,535.00 |
Open | 2,520.00 |
Bid | 2,480.00 x N/A |
Ask | 2,600.00 x N/A |
Day's range | 2,535.00 - 2,535.00 |
52-week range | 1,776.00 - 2,535.00 |
Volume | |
Avg. volume | 2 |
Market cap | 226.182B |
Beta (5Y monthly) | 0.96 |
PE ratio (TTM) | 15.85 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform Mako and its broad product portfolio.